Gene therapy abroad

Neurocrine Biosciences and Voyager Therapeutic announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy programs, VY-AADC for Parkinson’s disease and VY-FXN01 for Friedreich’s ataxia, as well as rights to two programs to be determined. This collaboration combines Neurocrine Biosciences’ expertise in neuroscience,...

Continue reading

CALL FOR APPLICATIONS:

Ataxia Canada: position posted on December 17, 2018. Closing date: Friday, December 28, 2018 at 4 pm Ataxia Canada – Claude St-Jean Foundation is looking for an intern – project manager Our foundation wishes to support the young talents of our organization in their quest for gainful employment. We therefore...

Continue reading